Neonatal and infant care and outcomes.

Area of Science:

• Neonatal care and Perinatology
• Clinical trials and Evidence-based medicine

Background:

• Surfactant replacement therapy represents a significant advancement in neonatal intensive care.
• Over 30 clinical trials support its efficacy, leading to widespread approval.
• Ongoing research aims to fully determine its clinical application and impact on patient outcomes.

Purpose of the Study:

• To analyze current neonatal outcome data and identify areas for improved survival.
• To address the need for clarity regarding survival rates in specific low gestational age cohorts.
• To highlight the importance of accurate gestational age assessment in neonatal care.

Main Methods:

• Review of neonatal outcome data from clinical trials and observational studies.
• Analysis of survival statistics stratified by birth weight and gestational age.
• Examination of methodologies for assessing gestational age in neonates.

Main Results:

• Neonatal survival improvements are now predominantly focused on extremely low birth weight infants (<750 g).
• There is a recognized need for more precise data on survival for infants born before 28 weeks of gestation.
• Understanding the nuances of gestational age assessment is crucial for accurate outcome interpretation.

Conclusions:

• Surfactant therapy has transformed neonatal care, with survival gains now centering on the most vulnerable infants.
• Accurate gestational age determination is critical for evaluating neonatal outcomes and guiding clinical practice.
• Further research should focus on optimizing care for preterm infants and refining assessment techniques.